Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
News
Press release - Grant for research project
Awarded a partially refundable grant for research project: Bluespe
Tue, 31/07/2018 - 00:00
1 min
Awarded a partially refundable grant for research project: Bluespe
Download related document
Select rating
Give Press release - Grant for research project 1/5
Give Press release - Grant for research project 2/5
Give Press release - Grant for research project 3/5
Give Press release - Grant for research project 4/5
Give Press release - Grant for research project 5/5
No votes yet
Related
ROVI receives the positive opinion of the CHMP on Okedi® as a treatment for...
Laboratorios Farmacéuticos Rovi, a pan-European pharmaceutical company specializing and engaging in the research, development, contract...
4 min
17/12/2021
2021 Capital Markets Day presentation
TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION (COMISIÓN NACIONAL DEL MERCADO DE VALORES) Madrid, 16 November 2021 In...
1 min
16/11/2021
First Nine Months 2021 Results Press Release
REVENUES Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specialized and dedicated to the...
5 min
03/11/2021
See More
Email
Facebook
Twitter
LinkedIn
Awarded a partially refundable grant for research project: Bluespe